Literature DB >> 29737538

Long non-coding RNA GAS5 aggravates hypoxia injury in PC-12 cells via down-regulating miR-124.

Xiaoli Hu1, Juan Liu2, Gang Zhao1, Jiaping Zheng2, Xia Qin2.   

Abstract

One important feature of cerebral ischemia is hypoxia injury in nerve cells. Growth arrest-specific transcript 5 (GAS5) is widely reported as a tumor suppressor gene; however, the investigations about its role in cerebrovascular disease are relatively rare. This study was aimed to explore the impact of GAS5 on hypoxia response in nervous cells. PC-12 cells were incubated under anoxic condition to induce hypoxia injury. Regulatory effects of GAS5 on miR-124 and miR-124 on ICAM-1 expression were assessed by qRT-PCR and/or Western blot. Targeting effect of miR-124 on ICAM-1 3'-untranslated regions (UTR) was evaluated through dual luciferase activity assay. The potential regulatory mechanism on hypoxia injury in PC-12 cells was assessed by detecting key elements of NF-κB and Notch signaling pathways using Western blot. GAS5 ectopic expression accentuated hypoxia injury in PC-12 cells. miR-124 expression was negatively regulated by GAS5 expression. Cells with overexpressions of GAS5 and miR-124 alleviated hypoxia injury as in compassion with cells only with GAS5 overexpression. ICAM-1 expression was negatively regulated by miR-124 expression. ICAM-1 was a functional target of miR-124. ICAM-1 overexpression aggravated hypoxia injury, but inversely, ICAM-1 silence diminished hypoxia damage. Besides, ICAM-1 expression was negatively related with activation of NF-κB and Notch pathways. GAS5-miR-124-ICAM-1 axis could regulate hypoxia injury in PC-12 cells. GAS5 might aggravate hypoxia injury via down-regulating miR-124, then up-regulating ICAM-1, and further enhancing activations of NF-κB and Notch pathways.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GAS5; ICAM-1; NF-κB pathway; Notch pathway; hypoxia injury; miR-124

Mesh:

Substances:

Year:  2018        PMID: 29737538     DOI: 10.1002/jcb.26870

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Protodioscin protects PC12 cells against oxygen and glucose deprivation-induced injury through miR-124/AKT/Nrf2 pathway.

Authors:  Kun Shu; Yuelin Zhang
Journal:  Cell Stress Chaperones       Date:  2019-08-24       Impact factor: 3.667

2.  HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2.

Authors:  Wen-Long Zhang; Ya-Nan Zhao; Zhang-Zhen Shi; Gui-Ying Gu; Dan Cong; Chen Wei; Yuan-Song Bai
Journal:  Hum Cell       Date:  2019-09-06       Impact factor: 4.174

3.  Silencing of Long Noncoding RNA GAS5 Blocks Experimental Cerebral Ischemia-Reperfusion Injury by Restraining AQP4 Expression via the miR-1192/STAT5A Axis.

Authors:  Zhongzhong Jiang; Min Liu; Dezhi Huang; Yang Cai; Yu Zhou
Journal:  Mol Neurobiol       Date:  2022-10-05       Impact factor: 5.682

4.  Silencing of Long Non-coding RNA GAS5 Suppresses Neuron Cell Apoptosis and Nerve Injury in Ischemic Stroke Through Inhibiting DNMT3B-Dependent MAP4K4 Methylation.

Authors:  Yiming Deng; Duanduan Chen; Feng Gao; Hong Lv; Guojun Zhang; Xuan Sun; Lian Liu; Dapeng Mo; Ning Ma; Ligang Song; Xiaochuan Huo; Tianyi Yan; Jingbo Zhang; Yun Luo; Zhongrong Miao
Journal:  Transl Stroke Res       Date:  2020-01-29       Impact factor: 6.800

5.  M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124.

Authors:  Yaying Song; Zongwei Li; Tingting He; Meijie Qu; Lu Jiang; Wanlu Li; Xiaojing Shi; Jiaji Pan; Linyuan Zhang; Yongting Wang; Zhijun Zhang; Yaohui Tang; Guo-Yuan Yang
Journal:  Theranostics       Date:  2019-05-04       Impact factor: 11.556

6.  Inhibition of lncRNA H19/miR-370-3p pathway mitigates neuronal apoptosis in an in vitro model of spinal cord injury (SCI).

Authors:  Xin Li; Yan Qian; Kaihua Tang; Yang Li; Rui Tao; Chunyan Gong; Li Huang; Kaiwen Zou; Lindong Liu
Journal:  Transl Neurosci       Date:  2021-03-01       Impact factor: 1.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.